Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q13769
UPID:
THOC5_HUMAN
Alternative names:
Functional spliceosome-associated protein 79; NF2/meningioma region protein pK1.3; Placental protein 39.2; hTREX90
Alternative UPACC:
Q13769; O60839; Q9UPZ5
Background:
THO complex subunit 5 homolog (THOC5) is a pivotal component of the TREX complex, playing a crucial role in mRNA transcription, processing, and nuclear export. It specifically associates with spliced mRNA, facilitating its export to the cytoplasm via the TAP/NFX1 pathway. THOC5 is also involved in transcription elongation, genome stability, and alternative polyadenylation site choice. It regulates the expression of key myeloid transcription factors, contributing to hematopoietic primitive cell survival and monocytic development.
Therapeutic significance:
Understanding the role of THO complex subunit 5 homolog could open doors to potential therapeutic strategies.